Atlas Trials

Phase III Multicenter Double Blind Controlled Trial of Human Immune Globulin Therapy in Previously Untreated Patients With Chronic Inflammatory Demyelinating Neuropathy

Clinical trial NCT00004286 · COMPLETED

Trial details

NCT number
NCT00004286
Sponsor
National Center for Research Resources (NCRR)
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Polyradiculoneuropathy, Chronic Inflammatory Demyelinating
Start date
1996-02-01
Enrollment
120

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.